| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2008 | US20080005807 Transgenic animals |
| 01/03/2008 | US20080004437 Cloned Genes Encoding Reverse Transcriptase lacking RNase H Activity |
| 01/03/2008 | US20080004435 Corticotropin releasing factor 2 receptor agonists |
| 01/03/2008 | US20080004433 Characterization of the GSK-3beta protein and methods of use thereof |
| 01/03/2008 | US20080004430 CNG3B: a novel cyclic nucleotide-gated cation channel |
| 01/03/2008 | US20080004355 Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same |
| 01/03/2008 | US20080004326 Method of Obtaining Idolocarbazoles Using Biosynthetic Rebeccamycin Genes |
| 01/03/2008 | US20080004231 Disease-Associated Protein |
| 01/03/2008 | US20080004230 SAM Riboswitch and Uses Thereof |
| 01/03/2008 | US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor |
| 01/03/2008 | US20080004228 New Expression Tools for Multiprotein Applications |
| 01/03/2008 | US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level |
| 01/03/2008 | US20080004206 Albumin fusion proteins |
| 01/03/2008 | US20080003683 Ce7-specific redirected immune cells |
| 01/03/2008 | US20080003682 treatment or prevention of infection through the expression of one or more RNA molecules that inhibit one or more aspects of the life cycle of a pathogen through RNA interference with a target nucleic acid; for human lymphadenopathy associated viral diseases |
| 01/03/2008 | US20080003681 Methods for altering cellular susceptibility to infection |
| 01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
| 01/03/2008 | US20080003677 Three dimensional vaginal tissue model containing immune cells |
| 01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
| 01/03/2008 | US20080003673 Novel human proteases and polynucleotides encoding the same |
| 01/03/2008 | US20080003658 Method for expression of small antiviral rna molecules within a cell |
| 01/03/2008 | US20080003646 Stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA); complementary determining regions; vectors, host cells; pharmacokinetics |
| 01/03/2008 | US20080003645 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/03/2008 | US20080003643 Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy |
| 01/03/2008 | US20080003640 Process for preparing highly optically pure L-amino acids, such as L-homophenylalanine (L-HPA) and the derivatives thereof, from N-protected amino acid by using the novel NAAAR combined with L-N-carbamoylase |
| 01/03/2008 | US20080003639 Comprising a polynucleotide encoding a polypeptide, wherein the polypeptide hydroxylates the 24-position of an oleanane-type triterpene; cell transformed by a genetic engineering technique with an enzyme gene which is concerned in biosynthesis of plant-derived soyasapogenol B (12-oleanene-3,22,24-triol) |
| 01/03/2008 | US20080003637 Methods for Separating Hepatic, Endothelial, or Hematopoietic Progenitor Cells From Cell Populations |
| 01/03/2008 | US20080003601 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 01/03/2008 | US20080003596 Vector and method for detecting the change in transcription amount |
| 01/03/2008 | US20080003577 Methods for arbitrary peptide synthesis |
| 01/03/2008 | US20080003570 Translation enhancer elements of genes encoding human Tau protein and human alpha-synuclein protein |
| 01/03/2008 | US20080003568 Method for Enriching and/or Separating Prokaryotic Dna Using a Protein that Specifically Bonds to Unmethylated Dna Containing Cpg-Motives |
| 01/03/2008 | US20080003563 Method for Manufacturing Specific Binding Molecules Against Selected Target Molecules, Kit, and Binding Molecules |
| 01/03/2008 | US20080003560 Tailor-made pluripotent stem cell and use of the same |
| 01/03/2008 | US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants |
| 01/03/2008 | US20080003237 Gram Positive Bacterial Cells Comprising a Disrupted Flagellin Gene, Flagellin-Based Fusion Proteins and Use in Removal of Metal Ions from a Liquid |
| 01/03/2008 | US20080003236 Adenovirus fiber shaft composition and methods of use |
| 01/03/2008 | US20080003233 Recombinant Vaccines Against Caligid Copepods (Sea Lice) and Antigen Sequences Thereof |
| 01/03/2008 | US20080003232 Cpg Single Strand Deoxynucleotides for Use as Adjuvant |
| 01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
| 01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |
| 01/03/2008 | US20080003223 Babesia canis vaccine |
| 01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
| 01/03/2008 | US20080003218 Anti-IgE antibodies |
| 01/03/2008 | US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor |
| 01/03/2008 | US20080003210 Non-human primate receptor tyrosine kinases |
| 01/03/2008 | US20080003204 Compositions and methods for treating cystic fibrosis |
| 01/03/2008 | US20080003203 Pseudotyped baculovirus to stimulate immunogenicity against avian influenza |
| 01/03/2008 | US20080003202 Modified interferon-beta (IFN-beta) polypeptides |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/03/2008 | US20080003199 IL-33 in the treatment and diagnosis of diseases and disorders |
| 01/03/2008 | DE60219221T2 DNS-Sequenzen mit anti-repressor Aktivität DNA sequences with anti-repressor activity |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | DE102007023986A1 Protein with uridine diphosphate (UDP)-glucose 4,6-dehydratase, UDP-4-keto-6-deoxyglucose 3,5-epimerase and UDP-4-ketorhamnose 4-ketoreductase activity useful for converting UDP-glucose to UDP-rhamnose |
| 01/03/2008 | DE102006026328A1 Verfahren zur Herstellung eines L-Lysin enthaltenden Futtermitteladditivs A method for producing an L-lysine-containing feed additive |
| 01/03/2008 | CA2657975A1 A method for achieving improved polypeptide expression |
| 01/03/2008 | CA2656551A1 Methods for altering cellular susceptibility to infection |
| 01/03/2008 | CA2656327A1 A method of modifying a macromolecule without prior extraction from a sample |
| 01/03/2008 | CA2656281A1 Short chain volatile hydrocarbon production using genetically engineered microalgae, cyanobacteria or bacteria |
| 01/03/2008 | CA2656228A1 Composition for nucleic-acid transfection |
| 01/03/2008 | CA2656107A1 Cancer therapy using bcl-xl-specific sina |
| 01/03/2008 | CA2655914A1 Soybean event 3560.4.3.5 and compositions and methods for the identification and/or detection thereof |
| 01/03/2008 | CA2655874A1 Antibody molecules which bind human il-17 |
| 01/03/2008 | CA2655849A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease |
| 01/03/2008 | CA2655774A1 Novel human acidic mammalian chitinase and use thereof |
| 01/03/2008 | CA2655725A1 Improvements in or relating to organic compounds |
| 01/03/2008 | CA2654812A1 Grg33, grg35, grg36, grg37, grg38, grg39, and grg50: novel epsp synthase genes conferring herbicide resistance |
| 01/03/2008 | CA2654269A1 Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | CA2652957A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/02/2008 | EP1873514A1 Biological information processing unit and method, program and recording medium |
| 01/02/2008 | EP1873260A1 Process for synthesizing nucleic acid |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873257A2 Compositions and methods for the inference of pigmentation traits |
| 01/02/2008 | EP1873252A2 Arabidopsis promoters |
| 01/02/2008 | EP1873251A1 Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells |
| 01/02/2008 | EP1873249A1 Method for producing an L-tyrosine over-producing bacterial strain |
| 01/02/2008 | EP1873248A1 Biological process using a glucose-6-phosphate isomerase |
| 01/02/2008 | EP1873247A1 Novel bifunctional trehalose synthase |
| 01/02/2008 | EP1873246A1 Biological process using a transaldolase |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873244A2 Methods and compositions for inhibiting neoplastic cell growth |
| 01/02/2008 | EP1873243A1 Isolation of RNA and DNA from a biological sample |
| 01/02/2008 | EP1873242A2 Filter device for the isolation of a nucleic acid |
| 01/02/2008 | EP1873241A1 Process for isolating nucleic acids |
| 01/02/2008 | EP1873240A1 hTERT GENE EXPRESSION REGULATORY GENE |
| 01/02/2008 | EP1873239A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 01/02/2008 | EP1873165A1 Cloning of honey bee allergen C |
| 01/02/2008 | EP1873164A1 High molecular weight poly-gamma-glutamic acid (> 2000 kDa) |
| 01/02/2008 | EP1872125A1 Isolation of inhibitor of ires-mediated translation |
| 01/02/2008 | EP1871890A2 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject |
| 01/02/2008 | EP1871889A1 A process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells |
| 01/02/2008 | EP1871887A2 NOVEL hTMC PROMOTER AND VECTORS FOR THE TUMOR-SELECTIVE AND HIGH-EFFICIENT EXPRESSION OF CANCER THERAPEUTIC GENES |
| 01/02/2008 | EP1871886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/02/2008 | EP1871885A1 Materials and methods for respiratory disease control in canines |
| 01/02/2008 | EP1871884A2 Porcine circovirus and helicobacter combination vaccines |
| 01/02/2008 | EP1871883A1 Process for the production of fine chemicals |
| 01/02/2008 | EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 01/02/2008 | EP1871881A2 Metabolic-based methods for modulating gene expression |
| 01/02/2008 | EP1871880A2 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |